{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:05:04Z","timestamp":1780628704696,"version":"3.54.1"},"reference-count":127,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This is the English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). As the first biologics for psoriasis in Japan, infliximab and adalimumab, anti\u2010tumor necrosis factor\u2010\u03b1 antibodies, became available in the field of dermatology in 2010, followed by ustekinumab, an anti\u2010interleukin (IL)\u201012\/IL\u201023p40 antibody, which was launched in Japan in 2011. Moreover, after 2015, three IL\u201017 inhibitors, the IL\u201017A antibody preparations secukinumab and ixekizumab, and an anti\u2010IL\u201017 receptor antibody preparation brodalumab were marketed. Furthermore, after 2018, the anti\u2010IL23p19 antibody preparations guselkumab and risankizumab, the TNF inhibitor certolizumab pegol, the IL\u201023 inhibitor tildrakizumab, and the anti\u2010IL\u201017A\/F antibody bimekizumab were marketed. It is important for physicians to select appropriate biologic therapy for each psoriatic patient after due consideration of disease factors, treatment factors, and patient background factors, sharing such information with patients. The followings can be listed as points to be considered for the selection of biologics: drug effects (e.g., strength of effectiveness, time to onset of effectiveness, effectiveness against arthritis, primary failure, secondary failure), safety (e.g., infections, administration\u2010related reactions, and relationships with other comorbidities), convenience for patients (e.g., hospital visit intervals, self\u2010injection, maintenance therapy at clinics, feasibility of drug discontinuation\/re\u2010administration), and payment (medical costs) borne by patients. This guidance has been prepared with the aim of allowing dermatologists experienced in the treatment of psoriasis to use biologics appropriately according to the circumstances of individual patients after consideration of the above\u2010mentioned factors.<\/jats:p>","DOI":"10.1111\/1346-8138.16691","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T05:59:42Z","timestamp":1672379982000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)"],"prefix":"10.1111","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-0355","authenticated-orcid":false,"given":"Hidehisa","family":"Saeki","sequence":"first","affiliation":[{"name":"Department of Dermatology Nippon Medical School  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokai University School of Medicine  Isehara Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-3182","authenticated-orcid":false,"given":"Akihiko","family":"Asahina","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Jikei University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Kojinkai Sapporo Skin Clinic  Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3187","authenticated-orcid":false,"given":"Atsuyuki","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology NTT Medical Center Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-4349","authenticated-orcid":false,"given":"Shinichi","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine Fukuoka University  Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-1259","authenticated-orcid":false,"given":"Yukari","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-1803","authenticated-orcid":false,"given":"Mayumi","family":"Komine","sequence":"additional","affiliation":[{"name":"Department of Dermatology Jichi Medical University  Shimotsuke Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-0216","authenticated-orcid":false,"given":"Shigetoshi","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kochi Medical School Kochi University  Kochi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-3033","authenticated-orcid":false,"given":"Hideshi","family":"Torii","sequence":"additional","affiliation":[{"name":"Division of Dermatology Tokyo Yamate Medical Center  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-3754","authenticated-orcid":false,"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of Medical Sciences  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Research Division for Development of Anti\u2010Infective Agents, Faculty of Medical Science and Welfare Tohoku Bunka Gakuen University  Sendai Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamitaro","family":"Ohtsuki","sequence":"additional","affiliation":[{"name":"Department of Dermatology Jichi Medical University  Shimotsuke Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"163","article-title":"The guideline and safety manual for use of anti\u2010TNF\u2010\u03b1 agents in psoriasis","volume":"120","author":"Ohtsuki M","year":"2010","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_9_3_1","first-page":"1561","article-title":"Guideline and safety manual for use of biologic agents in psoriasis (the 2011 version)","volume":"121","author":"Ohtsuki M","year":"2011","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12239"},{"key":"e_1_2_9_5_1","first-page":"1845","article-title":"Japanese guidance for use of biologics for psoriasis (2019 version)","volume":"129","author":"Ohtsuki M","year":"2019","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15196"},{"key":"e_1_2_9_7_1","unstructured":"Committee for reviewing the safety of molecularly targeted drugs for psoriasis Japanese Dermatological Association: for the use of infliximab BS. (Revised July 12 2022) [cited 2022 Aug 2]. Available from:https:\/\/www.dermatol.or.jp\/modules\/news\/index.php?content_id=1015(In Japanese)"},{"key":"e_1_2_9_8_1","unstructured":"Committee for reviewing the safety of molecularly targeted drugs for psoriasis Japanese Dermatological Association: for the use of adalimumab BS. (Created April 18 2022) [cited 2022 Aug 2]. Available from:https:\/\/www.dermatol.or.jp\/modules\/biologics\/index.php?content_id=3(In Japanese)"},{"key":"e_1_2_9_9_1","first-page":"2211","article-title":"Treatment guideline for pustular psoriasis (generalized), 2014 edition","volume":"125","author":"Terui T","year":"2015","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.021"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20967"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032268"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22805"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.04.014"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00971.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13214"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13698"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202347"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04515.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21306"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092767"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00748.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13001"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13409"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60725-4"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60726-6"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60140-9"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01347.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12046"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12214"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60594-2"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204655"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204741"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12668"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.011"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14878"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.013"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13911"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13306"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412679"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"e_1_2_9_45_1","first-page":"890","article-title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double\u2010blind, phase III FUTURE 5 study","volume":"77","author":"Mease P","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17002"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.153"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13622"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209709"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170429"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315231"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.10.009"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13785"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14702"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18068"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.1993"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216835"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501646"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.041"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15750"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30952-8"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14504"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14294"},{"key":"e_1_2_9_68_1","first-page":"826","article-title":"Long\u2010term efficacy of guselkumab for the treatment of moderate\u2010to\u2010severe psoriasis: results from the phase 3 VOYAGE 1 trial through two years","volume":"17","author":"Griffiths CEM","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30263-4"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31713-6"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30952-3"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14941"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221019"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203697"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203696"},{"key":"e_1_2_9_76_1","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000582","article-title":"4\u2010year results from the RAPID\u2010PsA phase 3 randomised placebo\u2010controlled trial of certolizumab pegol in psoriatic arthritis","volume":"4","author":"Heijde D","year":"2018","journal-title":"RMD Open"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00520-0"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00645-2"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15862"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18232"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19866"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15789"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15763"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16964"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102388"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00126-4"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102383"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01836-1"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16102"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.014"},{"key":"e_1_2_9_93_1","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.057"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.044"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15665"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16915"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001457"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217372"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30564-X"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_2_9_104_1","first-page":"497","article-title":"Treatment guidelines for latent tuberculosis infection","volume":"88","author":"The Prevention Committee and the Treatment Committee of the Japanese Society for Tuberculosis","year":"2013","journal-title":"Kekkaku"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-009-0197-6"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13503"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2017.01.002"},{"key":"e_1_2_9_108_1","unstructured":"Guideline Committee Japan College of Rheumatology\/guideline committee for RA therapeutic medicine: guidance for the use of TNF inhibitors for rheumatoid arthritis (RA). (Revised on February 1 2020) [cited 2022 Aug 2]. Available from:https:\/\/www.ryumachi\u2010jp.com\/info\/guideline_tnf.pdf(In Japanese)"},{"key":"e_1_2_9_109_1","first-page":"59","volume-title":"Consensus statements for medical practice: biological agents and lung disease","author":"The Japanese Respiratory Society Committee","year":"2014"},{"key":"e_1_2_9_110_1","first-page":"568","article-title":"Biologics and infections\/chemotherapy","volume":"65","author":"Watanabe A","year":"2017","journal-title":"Jpn J Chemother"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.12.003"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100266"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.2177\/jsci.40.109"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2155"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1960981"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-2-1"},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212196"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211384"},{"key":"e_1_2_9_119_1","unstructured":"The Japan College of Rheumatology Subcommittee for methotrexate (MTX) Treatment Guideline Formulation.Guideline for MTX therapy for rheumatoid arthritis (revised 2016 version). Website of the Japan College of Rheumatology;2016. (In Japanese)"},{"key":"e_1_2_9_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14926"},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex301"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa710"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02388-5"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000692"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00250-3"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205554"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.01.033"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475416631328"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.16691","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1346-8138.16691","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.16691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:12:32Z","timestamp":1692274352000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.16691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1111\/1346-8138.16691"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.16691","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"2022-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}